Study Design: Randomized controlled trial. The researcher measuring skin pH was blinded to group assignment. Objectives: To compare the skin surface pH changes associated with iontophoresis. The investigation was designed to address the question of whether significant skin pH changes occur under the cathode on the skin surface when performing iontophoresis and assessed the influence of different electrode-buffering systems intended to stabilize skin pH (surface). Background: Whether buffers are needed to stabilize skin pH during iontophoresis has not been thoroughly addressed in the literature. The effectiveness of immobile resins versus simple phosphate buffers is also unclear. Methods and Measures: Sixty volunteer subjects were administered iontophoresis of normal saline using buffered or nonbuffered electrode systems. Each subject participated in 1 of the 12 doses by electrode conditions (ie, 5 subjects per group). Surface skin pH was measured before and after iontophoresis with a flat-surface pH electrode in concert with an analog pH meter. The independent variables were electrode type (4 levels) and dosage (3 levels). The dependent variable was the change in skin surface pH. Results: A significant change in skin pH was found only when the treatment dose was 80 mNminute with a nonbuffered electrode (i = 3.14 2 1.09). Conclusions: The skin pH changes that occur during a properly delivered iontophoresis treatment at dosages of 20 and 40 mAlmin were small and not significantly different with or without the addition of buffers. Those pH changes associated with 80 mNmin doses were significantly greater when no buffer was employed but were stabilized by each of the buffers used in the study (preloaded immobile resins or simple phosphates added at point of treatment). ) Orthop Sports Phys Ther 1999;29:656-660.
I ontophoresis, also termed ion transfer, is the treatment technique in which ions in solution are driven into tissue via electric current. This method of percutaneous drug administration has proven advantageous in that it allows for rapid delivery of a drug in a noninvasive manner. Chien et a12 outlined several potential advantages of percutaneous drug delivery compared with oral or injection routes. These advantages include avoiding the risks associated with parented therapy, avoiding variations in absorption and metabolism, bypassing hepatic elimination, reducing potential for overdosing and underdosing, allowing the use of a drug with short half-life, simplifying therapeutic regimen, and allowing for the rapid termination of drug delivery if indicated.
Physical therapists are particularly interested in using iontophe resis for the delivery of anti-inflammatory substances. Many patients managed by physical therapists have musculoskeletal inflammatory conditions. Ionte phoresis offers a means of administering medication to a localized treatment area while minimizing systemic levels of the medicati~n.~ Acetate, chloride, hyaluronidase, dexamethasone, copper, zinc, and lidocaine have been used to treat edema, ischemic skin ulcers, hyperhidrosis, fungal infections, gouty arthritis, calcific tendinitis, and musculoskeletal inflammatory conditions and to produce local ane~thesia.~ Magnesium (magnesium sulfate) has been used to produce muscle relaxation, and salicylate (sodium salicylate) has been used for musculoskeletal inflammatory condit i o n~.~ The contemporary use of iontophoresis by physical therapists is primarily intended for the treatment of musculoskeletal inflammatory conditions and edema and for local anesthesia.Wstel10 and JeskeS have written a comprehensive review of the literature on iontophoresis. One factor that has concerned those who use iontophoresis in clinical practice is the potential for skin breakdown associated with the use of direct currentS Some have suggested that controlling or stabilizing pH is necessary to reduce the incidence of skin irritation and burns." Such a position is used to s u p port the use of buffers added to the iontophoretic system. Skin irritation, when it is noted, is commonly of greater significance under the cathode,Ig and so the use of buffers is often advocated in this location.
Leeming et a18 noted increased hydrogen production at the periphery of the cathode, which could cause a measurable shift in pH. Phipps et all5 reported significant pH lowering at the anode and an increase in pH at the cathode. Mandleco1I demonstrated pH increasing to 10.1 under the cathode in a 30minute iontophoresis treatment using current intensities of 2 4 mA. Sanderson et all6 suggested that discomfort and skin irritation were the result of pH changes.
Several authors have stated that skin charge and electro-osmotic flow are altered by changes in skin pH.4.6.'7 Therefore, pH is important in the transfer of medications due to changes in the electroosmotic effect. Whether organic compounds exist in an ionized or nonionized state is a pHdependent issue.S Because the ability to deliver an ion via electrical current may be dependent on pH and because some believe that pH shifts may damage skin, there have been calls to develop electrode systems that can stabilize pH.I5J6
If large shifts in pH do occur in a properly delivered iontophoresis treatment at dosages employed in the clinical environment, physical therapists should use a method to stabilize pH. However, it is not clear if changes in pH are significant during a properly delivered iontophoresis treatment. Furthermore, it is not clear if skin irritation is the result of pH changes or of some other factor. This last point is particularly intriguing in light of the report by Molitor and Fer-nandezI2 indicating that current density was the source of skin breakdown, even when pH was stabilized. Our study was designed to address the question of whether significant skin pH changes occur under the cathode on the surface of the skin when performing iontophoresis. In addition, we attempted to assess the impact of various electrode-buffering systems intended to stabilize pH under the cathode during iontophoretic treatment.
METHODS
Sixty adult human subjects (women = 58%, men = 42%), ranging in age from 21 to 63 years (2 = 31.2 years; SD = 1l.8), gave informed consent to participate in this study. This study was approved by the Institutional Review Board, Human Subjects Committee of Arkansas State University, Jonesboro, Arkansas. The subjects represented a sample of convenience. All subjects were volunteers. Most were students or faculty of health professions but were not knowledgeable regarding iontophoresis. Subjects received no compensation for participation in the study. Informed consent was facilitated by providing the subjects with a written description of the methodology related to the study and explaining the process in detail as necessary. All subjects were informed that they were free to withdraw from participation at any time. Subjects were randomly assigned to 1 of 12 groups. The researcher responsible for pH measurements was blinded to group assignment until all testing was completed. See Table 1 for an explanation of the groups. Seven of the 12 groups consisted of 3 women and 2 men. Three groups included of 2 women and 3 men. Each of the final 2 groups had 4 women and 1 man. The mean age of each group a p pears in Table 1 .
After providing consent, each subject had the volar surface of the wrist (from volar crease distally to a point 12.5 cm more proximal) and the area over the wrist flexor muscles (proximally from the medial epicondyle to 15 cm distal of the epicondyle) cleaned with isopropyl alcohol for 30 seconds to remove any skin oils, perfumes, body lotions, and so on that might interfere with electrical conduction. The patient's skin pH was then measured at the center of the volar wrist site with the Orion Research analog pH meter model 301 with an Orion Research flat surface electrode model 91-35 (Orion Research, Boston, Mass). The flat-surface electrode and pH meter were calibrated before and after each measurement using standard pH reference buffers (pH = 4, 7, and 10). The manufacturer states that the combination of electrode and meter used is accurate to within 22% for the full range of pin deflection (0-14 pH).I4
The return electrode (anode in our method) was then applied to the skin surface covering the wrist flexors (just distal to the medial epicondyle). The treatment electrode (cathode in our method) was (mean age = 34.9) (mean age = 29.3) n = 60: 5 per group. Groups 1-7: 3 women and 2 men. Groups 8-10: 2 women and 3 men. Groups 11-12: 4 women and 1 man. t Manufacturer does provide a phosphate buffer with electrode system and does recommend its use. We did not use the buffer in these groups to measure effect (groups 3, 7, and 1 1 ). saturated with normal saline, then applied to the volar surface of the wrist (area described above).
The conductive area of the treatment electrodes (cathode) used in this experiment varied from 12.5 cm2 to 25 cm2. The return electrodes used were at least 1.5 times as great in terms of surface area.
The electrodes were then attached to the electrical generator. The device used for this experiment was the Life-Tech Iontophor-I1 model 61 11 PM/DX (LifeTech Corporation, Houston, Tex), a device specifically designed to be used for iontophoresis. Direct current (negative polarity) was then delivered. The intensity of the current delivered was based on 2 factors.
First, patient comfort was always maintained. Current was increased slowly over a 2-to %minute time period until a maximum of 0.5 m A /~m -~ or until the patient reported the onset of any discomfort.' If discomfort was noted, the intensity was decreased until no discomfort was reported. Second, current density was never allowed to exceed 0.5 m A /~m -~ of treatment electrode (cathode) surface area.
Electrical current was then allowed to flow until the dosage for each group was completed. Dosage for iontophoresis is a product of current delivered multiplied by treatment time (eg, 2 mA X 20 minutes = 40 mA/min dosage).
At the completion of the predetermined dosage, the electrode system was removed, and the patient's pH at the volar wrist site was again measured and recorded. This postiontophoresis pH measurement was made immediately after the cessation of current flow. The patient was instructed to monitor the stimulation sites for the next 24 hours. Each subject was instructed to return the next day to report any skin irritations or breakdowns noted and to allow the researchers to inspect the stimulation sites. This above process was repeated with each of the subjects.
Trials were performed on the following 4 electrode types: (1) Empi Dupel (Empi, Inc, St. Paul, Minn) prebuffered electrodes (immobile resin buffer), (2) Iomed Trans Q (Iomed, Inc, Salt Lake City, Utah) prebuffered electrodes (immobile resin buffer), (3) DynaPak (Dynatronics Corp, Salt Lake City, Utah) electrodes (no buffer in electrode or added to treatment-buffer is provided and recommended by manufacturer but was omitted in this test), and (4) DynaPak electrode (phosphate buffer added to electrode with the "drug" at time of treatment-the addition of the phosphate buffer was done following the recommended manufacturer protocol). Dosages of 20 mA/min, 40 mA/min, and 80 mA/min were given with each of these electrode systems.
Data Analysis
The data were analyzed by a 2-way analysis of variance (ANOVA). While ANOVA procedures are fairly robust to departures from normality, we did test the data to determine if group variances were equal and if samples came from normal populations. The data passed the Levene test for normality and equal variance necessary to perform the ANOVA.'J Dosage (mA/min) and electrode type were independent variables. Electrode types had 4 levels (Empi Dupel buffered, Iomed Trans Q buffered, DynaPak with the provided phosphate buffer omitted, and DynaPak u s ing the recommended and provided phosphate buffer). Dosage was in 3 levels (20, 40, and 80 mA/min). Change in skin pH was the dependent variable. Change was defined as the difference in skin pH preiontophoresis to postiontophoresis for each trial. These differences were averaged across the subjects in the group to calculate mean change (the dependent variable) for that group.
A priori level of significance was set (P 5 .05). Post-hoc analysis on significant effects ( P 5 .05) was performed using Tukey's Honestly Significant Difference test.'"he data were analyzed using SPSS for Windows 8.0 software (SPSS, Inc, Chicago, Ill) the ANOVA summary table. The Figure graphically displays the mean pH changes for each dose by electrode combination. There was a statistically significant interaction effect between dosage and electrode type ( Table 3) . The post hoc test indicated that the skin pH change for the DynaPak electrode system employed without the recommended phosphate buffer at 80 mA/min was significantly different from dose electrode combinations at 20 mA/min (with or without buffer), 40 mA/min (with or without buffer), and 80 mA/min (with buffer; Figure) .
DISCUSSION
As can be seen from Table 2 , the data did not demonstrate any statistically significant pH change during iontophoresis until the treatment dosage was increased to 80 mA/min. The 2 electrode systems that have preloaded buffers were able to stabilize pH at this increased dose. It could be concluded that the electrodes with a preloaded buffering system (Empi Dupel and Iomed Trans Q) are effective at stabilizing pH under greater iontophoresis dosages. However, the same observation was made for the electrode system (DynaPak) that had no preloaded buffer. When a phosphate buffer was added to this electrode (as is recommended by and provided by the manufacturer), it too demonstrated a stabilized pH at the higher dose. Interestingly, at dosages of 20 and 40 mA/ min, no significant skin pH changes were seen to oc- cur under the cathode with or without a buffering system. Molitor and FernandezI2 suggested that current density might be a significant issue in the clinical use of direct currents for iontophoresis. We believe this to be a salient point. Our methods took current density into consideration in every case. At no time was current ever delivered at an density greater than 0.5 m A /~m -~ of conductive electrode surface. Patient comfort was always maintained. Current intensity was increased slowly over 1 to 2 minutes. This is important when one considers that no subject in this study demonstrated any skin breakdown. Even those subjects who received 80 mA/min dosage, with no buffer employed, demonstrated no visible skin irritation.
It should be noted that the purpose of this study was not to comment on the clinical effectiveness of iontophoresis as a treatment technique. Our design did not address the value of iontophoresis for treatment of any commonly encountered condition. It should also be pointed out that this study did not address issues such as competing ions and depth of penetration. Our only concern was whether significant pH changes did occur under the cathode on the surface of the skin and whether electrode-buffering systems could be used to stabilize any skin pH changes that might occur. We chose 20,40, and 80 mA/min doses to represent a continuum of dosage that was below, within, and above dosages commonly Attempts to control for internal validity were made by randomly assigning subjects to experimental groups, limiting subject participation to a single data collection session, and calibrating instruments used for data collection prior to each use. Therefore, threats to internal validity due to subject assignment, history, maturation, testing, regression to the mean, mortality, o r instrumentation were controlled to the best o f our ability. External validity was also consid- 
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Erratum
In "Skin pH Changes Associated with Iontophore-was a typographical error in the manuscript, which sis" (Guffey JS, Rutherford MJ, Payne W, Phillips C. occurred throughout the text and in Tables 1 and 2 group 1 (mean age = 28.2) group 2 (mean age = 24.4) group 3 (mean age = 32.5) group 4 (mean age = 38.6) group 5 (mean age = 34.1 group 6 (mean age = 34.5) group 7 (mean age = 24.5) group 8 (mean age = 34.9) group 9 (mean age = 32.9) group 10 (mean age = 24.1) group 11 (mean age = 37.5) group 12 (mean age = 29.3) * n = 60: 5 per group. Groups 1-7: 3 women and 2 men. Groups 8-10: 2 women and 3 men. Groups 11-12: 4 women and 1 man. t Manuiacturer does provide a phosphate buffer with electrode system and does recommend its use. We did not use the buifer in these groups to measure efiect (groups 3, 7, and 1 1 ). 
